请使用支持JavaScript的浏览器!
主营:基因芯片、二代测序NGS测序仪及相关测序试剂盒
banner
当前位置: 首页 > 产品中心 > Clinical Research Products > Illumina/TruSight RNA Fusion Panel Set A (48 samples)/RS-304-1002/1 Ea
公司介绍
Illumina公司,致力于新一代测序和芯片技术的生产与开发,提供最新的产品与应用资讯。Illumina公司创立于1998年4月,是遗传变异和生物学功能分析领域的优秀的产品、技术和服务供应商。通过帮助客户加快实现生物信息的采集、分析和应用,来改善人类健康。As a startup, Illumina aspired to transform human health. Our initial products enabled researchers to explore DNA at an en...

Illumina/TruSight RNA Fusion Panel Set A (48 samples)/RS-304-1002/1 Ea

Illumina/TruSight RNA Fusion Panel Set A (48 samples)/RS-304-1002/1 Ea
  • Illumina/TruSight RNA Fusion Panel Set A (48 samples)/RS-304-1002/1 Ea
商品介绍

ProductHighlights:

ThistargetedRNAsequencingpanelisacost-effectivesolutiontodetectgenefusionsinmultiplecancertypes,regardlessoforigin.Covering507fusion-associatedgenes,asingleassayenablesresearcherstoassessmostknowncancer-relatedfusionsinblood,bonemarrow,andFFPEsamples,withthepowertoidentifynovelfusiongenepartners.

  • Industry-validatedcontentforacomprehensiveviewofcancer-relatedfusiongenes,detectingcommonandnovelfusions
  • FromRNAtoresultsin4daysincludingon-instrumentsoftwarethatdisplaysfusioncalls
  • Compatibilitywithdesktopsequencerstomaximizelabbudgets
  • OptimizedRNAsequencingforallsampletypes,includingFFPEtissues
SimpleFusionReportforCustomersNewtoNGS

On-instrumentfusioncallingprovidesNGS-basedfusiondetectiontolabswithoutadditionalbioinformaticssupport.Theanalysisprovidesalistofdetectedfusions,relevantdiseaseassociations(asidentifiedbytheMitelmandatabase),andevidenceoffusion-supportingreads.

Robust,ReproducIBLe,andLow-InputFusionAssay

Thisassayaccommodatesaslittleinputas20ngFFPERNAor10ngfresh-frozentotalRNA.TheTruSightRNAFusionPanelprovidesasensitive,reproducible,andeconomicalsolutionforstudiesofgenefusionsincancerresearch.

Specifications:

AssayTime2.5days
Hands-OnTime11hours
InputQuantity10ngtotalRNA,20–100ngFFPERNA
SystemCompatibilityMiSeq,NextSeq550,MiSeqDxinResearchMode,MiniSeq,NextSeq500
MethodTargetedRNASequencing,SequencingforCytogenomics
VariantClassGeneFusions
SpecializedSampleTypesFFPE,LowInput
TechnologySequencing
SpeciesCategoryHuman
CancerTypePan-Cancer
品牌介绍

Illumina公司,致力于新一代测序和芯片技术的生产与开发,提供最新的产品与应用资讯。Illumina公司创立于1998年4月,是遗传变异和生物学功能分析领域的优秀的产品、技术和服务供应商。通过帮助客户加快实现生物信息的采集、分析和应用,来改善人类健康。

As a startup, Illumina aspired to transform human health. Our initial products enabled researchers to explore DNA at an entirely new scale, helping them create the first map of gene variations associated with health, disease, and drug response. Every breakthrough opened up a new world, and showed us how much further there is to go

While the rate of progress is accelerating exponentially, we are only beginning to understand the clinical significance of the genome. What causes a cancer cell to mutate? What is the origin of a puzzling disease? Is it possible to prevent the next outbreak? Or safeguard the world’s food supply? These are just a few of the challenges that inspire us to push the boundaries of our imagination

Today we are a global leader in genomics – an industry at the intersection of biology and technology. At the most fundamental level, we enable our customers to read and understand genetic variations. We strive to make our solutions increasingly simple, more accessible, and always reliable. As a result, discoveries that were unimaginable even a few years ago are now becoming routine – and are making their way into patient treatment.

We now have the ability to sequence at an unprecedented scale. Collectively, this will give us a much deeper understanding of genetics than ever before. We will begin to truly unlock the power of the genome. These advances will trigger a fundamental shift in healthcare and beyond. Medicine will continue to become more preventive and more precise. We will be healthier, longer. We have only just begun.

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics



蚂蚁淘(ebiomall)作为一家生命科学领域的垂直电商平台,公司专注生物医学科研用品的全球导购和品牌推广,为海内外厂方与代理经销商搭建跨境贸易系统和交流平台。产品齐全,200+分类,1000+品牌,500万+产品信息。100%正品,专业售后,到货快,在线下单, 简单轻松,节省科学家宝贵的科研时间。为您竭诚服务!

【订购】蚂蚁淘生物科技  联系方式:4000-520-616

更多产品,更多优惠!请联系我们!

苏州蚂蚁淘生物科技有限公司

免费热线:4000-520-616

官网:https://www.ebiomall.com/



Illumina-用于体外诊断的产品

产品信息图

Illumina COVIDSeq测试

这项高通量下一代测序(NGS)测试可从疑似COVID-19的患者的鼻咽,口咽和中鼻甲鼻拭子中检测出SARS-CoV-2。

产品信息图

MiSeqDx试剂盒v3

经过验证,经FDA认证,CE-IVD标记的测序试剂盒可用于MiSeqDx仪器,与以前的版本相比,质量得分更高。

产品信息图

NextSeq 550Dx试剂

这些测序试剂盒为体外诊断测试提供了简化的工作流程和高数据质量

产品信息图

实践扩展RAS面板

第一个FDA批准的NGS体外诊断为大肠癌评估RAS突变,以确定病人的资格与维克替治疗®

产品信息图

TruSeq定制扩增子试剂盒Dx

经过验证,经过FDA认证和CE-IVD标记的试剂盒使临床实验室能够设计自己的下一代测序测定法,以用于MiSeqDx和NextSeq 550Dx系统。

产品信息图

TruSight囊性纤维化

FDA批准的CE-IVD标记的下一代测序测试可在一种产品中方便地提供两种囊性纤维化测试分析。

产品信息图

VeriSeq NIPT解决方案v2

全面的IVD室内非整倍性筛选解决方案,提供试剂,仪器和软件,可在26小时内获得准确的NIPT结果。


自营商城图标
厂家直采
全球直采模式 正品优价
正品保障图标
正品保障
厂家直发 有线跟踪
解放采购图标
正规清关
CIF100%正规报关,提供发票
及时交付图标
及时交付
限时必达 不达必赔
在线客服
客服电话

4000-520-616

0512-67156496